CTI BioPharma Corp (CTIC) – Strategy, SWOT and Corporate Finance Report
- Pages: 49
- Published: June 2023
- Report Code: MLPH34546FSA
CTI BioPharma Corp (CTIC) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
CTI BioPharma Corp (CTI BioPharma) is a biopharmaceutical company that acquires, develops, and commercializes novel therapies for a range of blood-related cancers. Its lead product, Pacritinib is intended for the treatment of patients with myeloproliferative diseases. Its product pipeline includes PACIFICA for the treatment of myelofibrosis patients with severe thrombocytopenia; PAC203 for the patients with ruxolitinib therapy failure; PRE-VENT for COVID-19; PERSIST 1 for all platelets count and PERSIST 2 for platelets counts less than thousand. The company’s commercialized product, Vonjo is targeted for the treatment of adult patients with myelofibrosis patients with severe thrombocytopenia. The company relies on third parties for manufacturing and marketing its products. CTI BioPharma is headquartered in Seattle, Washington, the US.
Scope
• Detailed information on CTI BioPharma Corp required for business and competitor intelligence needs
• A study of the major internal and external factors affecting CTI BioPharma Corp in the form of a SWOT analysis
• An in-depth view of the business model of CTI BioPharma Corp including a breakdown and examination of key business segments
• News about CTI BioPharma Corp, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of CTI BioPharma Corp and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess CTI BioPharma Corp as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on CTI BioPharma Corps business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Clovis Oncology Inc
Bristol-Myers Squibb Co
Geron Corp
Novartis AG
Johnson & Johnson
Incyte Corp
Clovis Oncology Inc
Novartis AG
Incyte Corp
Geron Corp
Bristol-Myers Squibb Co
Johnson & Johnson
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.